Diagnostic accuracy of a bedside qualitative immunochromatographic test for acute myocardial infarction

Jamal A Alhashemi1

  • 1Department of Anesthesia and Critical Care, King Abdulaziz University, King Abdulaziz University Hospital, Jeddah, Saudi Arabia. jalhashemi@kau.edu.sa

Insights

CardioDetect, a point-of-care test, reliably diagnoses acute myocardial infarction within 12 hours using heart-type fatty acid-binding protein. This bedside test shows high sensitivity and specificity in emergency departments.

Area of Science:

  • Cardiology
  • Biomarker Detection
  • Point-of-Care Diagnostics

Background:

  • Early diagnosis of acute myocardial infarction (AMI) is critical for patient outcomes.
  • Traditional diagnostic methods may have limitations in rapid assessment in emergency settings.
  • Heart-type fatty acid-binding protein (H-FABP) is an emerging biomarker for cardiac injury.

Purpose of the Study:

  • To evaluate the diagnostic efficacy of the CardioDetect bedside immunochromatographic test.
  • To assess CardioDetect's ability to identify human heart-type fatty acid-binding protein in whole blood for AMI diagnosis.
  • To compare CardioDetect's performance against established cardiac biomarkers like troponin I (TnI) and creatine kinase (CK).

Main Methods:

  • Sixty-four patients presenting with chest pain underwent the CardioDetect test.
  • Serial serum troponin I (TnI) and creatine kinase (CK) levels were determined.
  • CardioDetect results were interpreted by blinded observers; AMI diagnosis was made by a blinded physician. Diagnostic accuracy metrics and reliability were assessed.

Main Results:

  • Within 4 hours of chest pain onset, CardioDetect demonstrated 62.5% sensitivity and 100% specificity, outperforming TnI and CK.
  • Between 4 and 12 hours, CardioDetect and TnI achieved 100% sensitivity, while CK showed 85.7%.
  • High intraobserver agreement (kappa >0.80) and interobserver reliability (intraclass correlation coefficient >0.90) were observed for CardioDetect.

Conclusions:

  • CardioDetect is a reliable point-of-care test for the early diagnosis of acute myocardial infarction.
  • The test is effective for rapid AMI detection within the first 12 hours in the emergency department.
  • CardioDetect offers a valuable bedside tool for timely cardiac assessment.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Automated Microbial Diagnostics01:24

Automated Microbial Diagnostics

Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...